283 related articles for article (PubMed ID: 16387861)
21. Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy.
Gardner KL; Kearney JA; Edwards JD; Rafael-Fortney JA
Gene Ther; 2006 May; 13(9):744-51. PubMed ID: 16307000
[TBL] [Abstract][Full Text] [Related]
22. Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene.
Vincent N; Ragot T; Gilgenkrantz H; Couton D; Chafey P; Grégoire A; Briand P; Kaplan JC; Kahn A; Perricaudet M
Nat Genet; 1993 Oct; 5(2):130-4. PubMed ID: 8252038
[TBL] [Abstract][Full Text] [Related]
23. Gene delivery to dystrophic muscle.
Wells KE; McMahon J; Foster H; Ferrer A; Wells DJ
Methods Mol Biol; 2008; 423():421-31. PubMed ID: 18370219
[TBL] [Abstract][Full Text] [Related]
24. A highly functional mini-dystrophin/GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophy.
Li S; Kimura E; Ng R; Fall BM; Meuse L; Reyes M; Faulkner JA; Chamberlain JS
Hum Mol Genet; 2006 May; 15(10):1610-22. PubMed ID: 16595609
[TBL] [Abstract][Full Text] [Related]
25. Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology.
Alter J; Lou F; Rabinowitz A; Yin H; Rosenfeld J; Wilton SD; Partridge TA; Lu QL
Nat Med; 2006 Feb; 12(2):175-7. PubMed ID: 16444267
[TBL] [Abstract][Full Text] [Related]
26. Genomic integration of the full-length dystrophin coding sequence in Duchenne muscular dystrophy induced pluripotent stem cells.
Farruggio AP; Bhakta MS; du Bois H; Ma J; P Calos M
Biotechnol J; 2017 Apr; 12(4):. PubMed ID: 28139886
[TBL] [Abstract][Full Text] [Related]
27. The mouse dystrophin muscle promoter/enhancer drives expression of mini-dystrophin in transgenic mdx mice and rescues the dystrophy in these mice.
Anderson CL; De Repentigny Y; Cifelli C; Marshall P; Renaud JM; Worton RG; Kothary R
Mol Ther; 2006 Nov; 14(5):724-34. PubMed ID: 16807118
[TBL] [Abstract][Full Text] [Related]
28. [Expression of the human dystrophin gene in mdx mouse muscle fibers after transfection using liposomes and synthetic oligopeptides].
Baranov VS; Tarasenko OV; Baranov VS; Tarasenko OV; Baranov AN; Kiselev AV; Ivashchenko TE; Evgrafov OV; Mikhailov Vm; Dickson G
Genetika; 1998 Jul; 34(7):876-82. PubMed ID: 9749328
[TBL] [Abstract][Full Text] [Related]
29. Long-term expression of full-length human dystrophin in transgenic mdx mice expressing internally deleted human dystrophins.
Ferrer A; Foster H; Wells KE; Dickson G; Wells DJ
Gene Ther; 2004 Jun; 11(11):884-93. PubMed ID: 14985788
[TBL] [Abstract][Full Text] [Related]
30. Long-term hepatitis C internal ribosome entry site-dependent gene expression mediated by phage phiC31 integrase in mouse model.
Sun Z; Wang Y; Fu Q; Zhou Y; Jia S; Du J; Peng J; Wang Y; Yang S; Zhan L
Antivir Ther; 2009; 14(3):393-400. PubMed ID: 19474473
[TBL] [Abstract][Full Text] [Related]
31. Immune rejection of human dystrophin following intramuscular injections of naked DNA in mdx mice.
Braun S; Thioudellet C; Rodriguez P; Ali-Hadji D; Perraud F; Accart N; Balloul JM; Halluard C; Acres B; Cavallini B; Pavirani A
Gene Ther; 2000 Sep; 7(17):1447-57. PubMed ID: 11001364
[TBL] [Abstract][Full Text] [Related]
32. Factors influencing the efficacy, longevity, and safety of electroporation-assisted plasmid-based gene transfer into mouse muscles.
Molnar MJ; Gilbert R; Lu Y; Liu AB; Guo A; Larochelle N; Orlopp K; Lochmuller H; Petrof BJ; Nalbantoglu J; Karpati G
Mol Ther; 2004 Sep; 10(3):447-55. PubMed ID: 15336645
[TBL] [Abstract][Full Text] [Related]
33. Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin.
Rooney JE; Welser JV; Dechert MA; Flintoff-Dye NL; Kaufman SJ; Burkin DJ
J Cell Sci; 2006 Jun; 119(Pt 11):2185-95. PubMed ID: 16684813
[TBL] [Abstract][Full Text] [Related]
34. A canine minidystrophin is functional and therapeutic in mdx mice.
Wang B; Li J; Qiao C; Chen C; Hu P; Zhu X; Zhou L; Bogan J; Kornegay J; Xiao X
Gene Ther; 2008 Aug; 15(15):1099-106. PubMed ID: 18432277
[TBL] [Abstract][Full Text] [Related]
35. Developments in gene therapy for muscular dystrophy.
Hartigan-O'Connor D; Chamberlain JS
Microsc Res Tech; 2000 Feb 1-15; 48(3-4):223-38. PubMed ID: 10679969
[TBL] [Abstract][Full Text] [Related]
36. Dystrophin gene repair in mdx muscle precursor cells in vitro and in vivo mediated by RNA-DNA chimeric oligonucleotides.
Bertoni C; Rando TA
Hum Gene Ther; 2002 Apr; 13(6):707-18. PubMed ID: 11936970
[TBL] [Abstract][Full Text] [Related]
37. [Development of new therapy on muscular dystrophy].
Takeda S
Rinsho Shinkeigaku; 2001 Dec; 41(12):1154-6. PubMed ID: 12235824
[TBL] [Abstract][Full Text] [Related]
38. Noninvasive monitoring of therapeutic gene transfer in animal models of muscular dystrophies.
Bartoli M; Poupiot J; Goyenvalle A; Perez N; Garcia L; Danos O; Richard I
Gene Ther; 2006 Jan; 13(1):20-8. PubMed ID: 16107863
[TBL] [Abstract][Full Text] [Related]
39. Electroporation of corrective nucleic acids (CNA) in vivo to promote gene correction in dystrophic muscle.
Kapsa RM; Wong SH; Quigley AF
Methods Mol Biol; 2008; 423():405-19. PubMed ID: 18370218
[TBL] [Abstract][Full Text] [Related]
40. Exogenous Dp71 restores the levels of dystrophin associated proteins but does not alleviate muscle damage in mdx mice.
Greenberg DS; Sunada Y; Campbell KP; Yaffe D; Nudel U
Nat Genet; 1994 Dec; 8(4):340-4. PubMed ID: 7894483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
